BusinessLaurus Labs Profit Climbs 126% as Q2 EBITDA Margin Widens to 34.5%By Helena WardOct 29, 2026, 2:09 PM UTC
InvestingSyngene Shares Gain 12.19%; Quarterly Profit Returns SequentiallyBy Celia RowanOct 28, 2026, 2:53 PM UTC
BusinessAvid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process SciencesBy Nasdaq OMXMay 8, 2018, 12:05 PM UTC
BusinessAvid Bioservices Receives Six 2018 CMO Leadership AwardsBy Nasdaq OMXMar 22, 2018, 12:05 PM UTC
BusinessPCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San DiegoBy Nasdaq OMXFeb 27, 2018, 2:15 PM UTC
BusinessAvid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant SciencesBy Nasdaq OMXFeb 21, 2018, 1:05 PM UTC
BusinessPCI Synthesis Submits Patent for Synthesizing Azelaic AcidBy Nasdaq OMXJan 30, 2018, 2:15 PM UTC
